These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 17447372

  • 1. Central nervous system toxoplasmosis in adult Ethiopians.
    Amogne W, Teshager G, Zenebe G.
    Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
    [Abstract] [Full Text] [Related]

  • 2. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS, Kalra SP, Singh AP, Gupta RM, Sanchetee PC.
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [Abstract] [Full Text] [Related]

  • 3. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico.
    del Rio-Chiriboga C, Orzechowski-Rallo A, Sanchez-Mejorada G.
    Arch Med Res; 1997 Jul; 28(4):527-30. PubMed ID: 9428578
    [Abstract] [Full Text] [Related]

  • 4. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Grünewald T, Behnsch M, Grobusch M, Vallée M, Wünsche T, Ruf B, Suttorp N.
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [Abstract] [Full Text] [Related]

  • 5. [Value of magnetic resonance in the diagnostic definition of neurotoxoplasmosis and in the assessment of the response to pharmacological treatment].
    Sparacia G, Brancatelli G, Sarno C, De Maria M, Lagalla R, Filosto L.
    Radiol Med; 1998 Jan; 96(1-2):23-8. PubMed ID: 9819614
    [Abstract] [Full Text] [Related]

  • 6. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
    Teira R, Virosta M, Baraia-Etxaburu J, Muñoz J, Zubero Z, Cisterna R, Santamaría JM.
    Enferm Infecc Microbiol Clin; 1999 Jan; 17(7):347-9. PubMed ID: 10535188
    [Abstract] [Full Text] [Related]

  • 7. [Opportunistic infections in HIV-infected subjects: no wonders].
    Ermak TN, Peregudova AV, Gruzdev BM.
    Ter Arkh; 2006 Jan; 78(11):80-1. PubMed ID: 17195535
    [No Abstract] [Full Text] [Related]

  • 8. [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
    Guelar A, Miró JM, Mallolas J, Zamora L, Cardenal C, Gatell JM, Soriano E.
    Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):137-40. PubMed ID: 8011719
    [Abstract] [Full Text] [Related]

  • 9. [Cerebral toxoplasmosis and AIDS in Martinique].
    Bourée P, Dumazedier D, Magdeleine C, Sobesky G.
    Med Trop (Mars); 1997 Mar; 57(3):259-61. PubMed ID: 9513153
    [Abstract] [Full Text] [Related]

  • 10. [Fansidar in the treatment of toxoplasmosis].
    Michalová K, Ríhová E, Havlíková M.
    Cesk Slov Oftalmol; 1996 Jul; 52(3):173-8. PubMed ID: 8768475
    [Abstract] [Full Text] [Related]

  • 11. Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine.
    Bouboulis DA, Rubinstein A, Shliozberg J, Madden J, Frieri M.
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):491-4. PubMed ID: 7788516
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Wünsche T, Grünewald T, Schürmann M, Grobusch M, Vallée M, Ruf B, Suttorp N.
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [Abstract] [Full Text] [Related]

  • 13. [Cerebral toxoplasmosis during AIDS in the infectious diseases department of Point-G Teaching Hospital, Bamako, Mali].
    Goïta D, Karambe M, Dembélé JP, Sogoba D, Sidibé AF, Diaby S, Cisse IA, Fongoro S, Dao S.
    Mali Med; 2012 May; 27(1):47-50. PubMed ID: 22765969
    [Abstract] [Full Text] [Related]

  • 14. Cerebral toxoplasmosis in an AIDS patient.
    Saito T, Takeuchi S, Taguchi H, Miyoshi I.
    Intern Med; 2003 Jan; 42(1):131. PubMed ID: 12583637
    [No Abstract] [Full Text] [Related]

  • 15. [HIV-associated cerebral toxoplasmosis -- review and retrospective analysis of 36 patients].
    Happe S, Fischer A, Heese Ch, Reichelt D, Grüneberg U, Freund M, Kloska S, Evers S, Husstedt IW.
    Nervenarzt; 2002 Dec; 73(12):1174-8. PubMed ID: 12486567
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S, Samintarapanya K, Oranratnachai K, Prapakarn W, Apichartpiyakul C.
    J Int Assoc Physicians AIDS Care (Chic); 2008 Dec; 7(1):11-6. PubMed ID: 17517949
    [Abstract] [Full Text] [Related]

  • 17. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.
    Porter SB, Sande MA.
    N Engl J Med; 1992 Dec 03; 327(23):1643-8. PubMed ID: 1359410
    [Abstract] [Full Text] [Related]

  • 18. A solitary brain lesion in a patient with AIDS.
    Ball SC.
    AIDS Read; 2003 Jan 03; 13(1):11-4. PubMed ID: 12569890
    [No Abstract] [Full Text] [Related]

  • 19. Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection.
    Ho YC, Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SC.
    J Microbiol Immunol Infect; 2008 Oct 03; 41(5):386-92. PubMed ID: 19122919
    [Abstract] [Full Text] [Related]

  • 20. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
    Foot AB, Garin YJ, Ribaud P, Devergie A, Derouin F, Gluckman E.
    Bone Marrow Transplant; 1994 Aug 03; 14(2):241-5. PubMed ID: 7994239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.